Lakefront Biotherapeutics | GLPG - Le Coût Des Ventes





Le Coût Des Ventes Changement Date
argenx SE USD 145M 24M 2026-06
AstraZeneca USD 2.52B 2.73B 2026-06
Biogen USD 945.1M 147.6M 2026-06
Genmab DKK 84M 19M 2026-06
Gilead Sciences USD 1000M 445M 2026-06
GlaxoSmithKline GBP 2.07B 192M 2026-06
GRIFOLS EUR 1.17B 90M 2026-06
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Incyte USD 104.96M 457K 2026-06
Merck EUR 2.27B 199M 2026-06
Neurocrine Biosciences USD 39.4M 25.6M 2026-06
Novartis USD 3.71B 251M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.02B 656M 2026-06
UCB EUR 1.07B 146M 2025-12
Vertex Pharmaceuticals USD 489.2M 96.4M 2026-06